DK1908760T3 - Chromatic and thiochroman-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine beta-hydroxylase and methods for their preparation - Google Patents

Chromatic and thiochroman-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine beta-hydroxylase and methods for their preparation

Info

Publication number: DK1908760T3
Authority: DK; Denmark
Prior art keywords: dihydroimidazoles; thiochroman; hydroxylase; chromatic; inhibitors
Prior art date: 2002-10-11

Application number

DK07076125.9T

Other languages

Danish (da)

Inventor

David Alexander Learmonth

Da Silva Patricio Manuel Vieira Araujo Soares

Alexander Beliaev

Original Assignee

Bial Portela & Ca Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-11

Filing date

2003-10-10

Publication date

2011-07-25

2003-10-10 Application filed by Bial Portela & Ca Sa filed Critical Bial Portela & Ca Sa

2003-10-10 Priority claimed from EP03256420A external-priority patent/EP1408038B1/en

2011-07-25 Application granted granted Critical

2011-07-25 Publication of DK1908760T3 publication Critical patent/DK1908760T3/en

Links

FVVJXNLMRXNHCY-UHFFFAOYSA-N 3-(3,4-dihydro-2h-thiochromen-3-yl)-1,2-dihydroimidazole Chemical class C1NC=CN1C1CC2=CC=CC=C2SC1 FVVJXNLMRXNHCY-UHFFFAOYSA-N 0.000 title 1
108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK07076125.9T 2002-10-11 2003-10-10 Chromatic and thiochroman-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine beta-hydroxylase and methods for their preparation DK1908760T3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0223719A GB2393958A (en)	2002-10-11	2002-10-11	Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
GB0224306A GB2394223B (en)	2002-10-11	2002-10-18	Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation
EP03256420A EP1408038B1 (en)	2002-10-11	2003-10-10	Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase

Publications (1)

Publication Number	Publication Date
DK1908760T3 true DK1908760T3 (en)	2011-07-25

Family

ID=9945777

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK03256420T DK1408038T3 (en)	2002-10-11	2003-10-10	Imidazole derivatives and their use as peripherally selective inhibitors dopamine beta-hydroxylase
DK07076125.9T DK1908760T3 (en)	2002-10-11	2003-10-10	Chromatic and thiochroman-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine beta-hydroxylase and methods for their preparation

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK03256420T DK1408038T3 (en)	2002-10-11	2003-10-10	Imidazole derivatives and their use as peripherally selective inhibitors dopamine beta-hydroxylase

Country Status (10)

Country	Link
KR (1)	KR101350741B1 (en)
CN (1)	CN100393715C (en)
AR (2)	AR041589A1 (en)
AT (5)	ATE403652T1 (en)
CY (2)	CY1108452T1 (en)
DE (4)	DE60322642D1 (en)
DK (2)	DK1408038T3 (en)
ES (5)	ES2364919T3 (en)
GB (2)	GB2393958A (en)
SI (2)	SI1908760T1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0708818D0 (en) *	2007-05-08	2007-06-13	Portela & Ca Sa	Compounds
JP6161538B2 (en) *	2010-12-22	2017-07-12	バイアル−ポルテラアンドシーエー，エス．エー．	Crystal form and manufacturing method thereof
GB201316410D0 (en) *	2013-09-13	2013-10-30	Bial Portela & Ca Sa	Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL82401A0 (en) *	1986-05-06	1987-11-30	Merrell Dow Pharma	Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them
US4868210A (en)	1988-03-30	1989-09-19	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic compounds and compositions
WO1995029165A2 (en) *	1994-04-26	1995-11-02	Syntex (U.S.A.) Inc.	Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors

2002
- 2002-10-11 GB GB0223719A patent/GB2393958A/en not_active Withdrawn
- 2002-10-18 GB GB0224306A patent/GB2394223B/en not_active Expired - Lifetime
2003
- 2003-10-10 AT AT03256420T patent/ATE403652T1/en active
- 2003-10-10 ES ES07076125T patent/ES2364919T3/en not_active Expired - Lifetime
- 2003-10-10 DE DE60322642T patent/DE60322642D1/en not_active Expired - Lifetime
- 2003-10-10 DE DE60336275T patent/DE60336275D1/en not_active Expired - Lifetime
- 2003-10-10 AT AT07076124T patent/ATE500247T1/en not_active IP Right Cessation
- 2003-10-10 DK DK03256420T patent/DK1408038T3/en active
- 2003-10-10 ES ES07076123T patent/ES2384118T3/en not_active Expired - Lifetime
- 2003-10-10 CN CNB2003801059426A patent/CN100393715C/en not_active Expired - Fee Related
- 2003-10-10 AT AT07076125T patent/ATE505465T1/en active
- 2003-10-10 AT AT07076123T patent/ATE550335T1/en active
- 2003-10-10 KR KR1020127005102A patent/KR101350741B1/en not_active Expired - Fee Related
- 2003-10-10 ES ES07076124T patent/ES2361939T3/en not_active Expired - Lifetime
- 2003-10-10 DE DE60336772T patent/DE60336772D1/en not_active Expired - Lifetime
- 2003-10-10 DK DK07076125.9T patent/DK1908760T3/en active
- 2003-10-10 AR ARP030103711A patent/AR041589A1/en active IP Right Grant
- 2003-10-10 DE DE60336276T patent/DE60336276D1/en not_active Expired - Lifetime
- 2003-10-10 ES ES07076122T patent/ES2361938T3/en not_active Expired - Lifetime
- 2003-10-10 ES ES03256420T patent/ES2309279T3/en not_active Expired - Lifetime
- 2003-10-10 AT AT07076122T patent/ATE500248T1/en not_active IP Right Cessation
- 2003-10-10 SI SI200331986T patent/SI1908760T1/en unknown
- 2003-10-10 SI SI200331309T patent/SI1408038T1/en unknown
2008
- 2008-10-24 CY CY20081101204T patent/CY1108452T1/en unknown
2011
- 2011-07-01 CY CY20111100639T patent/CY1112457T1/en unknown
2014
- 2014-03-18 AR ARP140101283A patent/AR095674A2/en unknown

Also Published As

Publication number	Publication date
ATE505465T1 (en)	2011-04-15
CY1112457T1 (en)	2015-12-09
ES2364919T3 (en)	2011-09-16
KR20120038014A (en)	2012-04-20
SI1908760T1 (en)	2011-05-31
HK1116188A1 (en)	2008-12-19
DE60336276D1 (en)	2011-04-14
DE60336275D1 (en)	2011-04-14
GB0224306D0 (en)	2002-11-27
ATE550335T1 (en)	2012-04-15
CN1726211A (en)	2006-01-25
GB2394223B (en)	2007-05-16
AR041589A1 (en)	2005-05-26
DK1408038T3 (en)	2008-11-24
ES2309279T3 (en)	2008-12-16
CN100393715C (en)	2008-06-11
ATE500248T1 (en)	2011-03-15
KR101350741B1 (en)	2014-01-10
ES2361939T3 (en)	2011-06-24
ES2361938T3 (en)	2011-06-24
ATE500247T1 (en)	2011-03-15
DE60336772D1 (en)	2011-05-26
GB2393958A (en)	2004-04-14
ES2384118T3 (en)	2012-06-29
GB2394223A (en)	2004-04-21
AR095674A2 (en)	2015-11-04
SI1408038T1 (en)	2008-10-31
ATE403652T1 (en)	2008-08-15
DE60322642D1 (en)	2008-09-18
GB0223719D0 (en)	2002-11-20
CY1108452T1 (en)	2014-04-09

Publication	Publication Date	Title
DK2332909T3 (en)	2014-11-10	HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90
DK1664043T3 (en)	2008-03-25	Compositions suitable as inhibitors of protein kinases
DK1562589T3 (en)	2009-02-16	Diaminotriazoles useful as inhibitors of protein kinases
DK1713806T3 (en)	2013-08-05	Compounds and Compositions as Protein Kinase Inhibitors
DK1791852T3 (en)	2009-04-06	C-aryl glucoside -SGLT2 inhibitors and method for their preparation
DK1931645T3 (en)	2014-09-29	N- (3-aminoquinoxalin-2-yl) -sulfonamide derivatives and their use as inhibitors of phosphatidylinositol-3-kinase
DK1789041T3 (en)	2008-09-08	Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
DK1585749T3 (en)	2008-09-22	Diazepinoindole derivatives as kinase inhibitors
DK1797042T3 (en)	2009-03-02	Indozolone derivatives as 11B-HSD1 inhibitors
DK1686999T3 (en)	2009-10-05	Pyrazole derivatives as inhibitors of receptor tyrosine kinases
DK1527050T3 (en)	2010-07-19	Quinoline derivatives and their use as mycobacterial inhibitors
DK1701946T3 (en)	2008-04-28	1-piperazine and 1-homopiperazine carboxylate derivatives, their preparation and their therapeutic use as inhibitors of the FAAH enzyme
DK1711481T3 (en)	2010-04-19	Process for Preparation of 2-Aminothiazole-5-Aromatic Carboxamides as Kinase Inhibitors
DK1730146T3 (en)	2011-08-15	Azaindoles useful as inhibitors of JAK and other protein kinases
DK1786785T3 (en)	2010-05-31	Enantiomerically pure amino heteroaryl compounds as protein kinase inhibitors
DK2439205T3 (en)	2015-06-22	Carboxamide compounds and their use as calpain inhibitors
DK1667986T3 (en)	2013-05-06	Acetonesolvate of dimethoxydocetaxel and process for its preparation
DK1848430T3 (en)	2017-11-06	NEW BENZYLAMINE DERIVATIVES AS CETP INHIBITORS
DK3305776T3 (en)	2019-12-09	PYRROL COMPOUNDS AS INHIBITORS OF ERK-PROTEIN KINASES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DK1556375T3 (en)	2008-11-03	Flavone derivatives as inhibitors of cyclin-dependent kinases
DK1641780T3 (en)	2009-02-02	Methods for Preparation of 1 - [(benzimidazol-1yl) quinolin-8-yl] -piperidin-4-ylamine derivatives
DK1670458T3 (en)	2007-04-23	1-Amino-2-oxy-substituted tetrahydronaphthalane derivatives, processes for their preparation and their use as antiphlogistics
DK2081895T3 (en)	2013-04-22	HYDROBENZAMIDE DERIVATIVES AS INHIBITORS OF HSP90
NO20050665L (en)	2005-04-18	Pyrrolidone derivatives as MAOE inhibitors
DK1928840T3 (en)	2011-09-12	1H-pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors